Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001879713-25-000002·Cardiol Therapeutics Inc.
Schedule 13G ownership disclosure
CARDIOL THERAPEUTICS INC
Class A Common Shares · CUSIP: 14161Y200
Event date: 2025-10-17
- Filing-level shares
- 5,130,122.00
- Percent of class
- 5.2%
- Tejara Capital Ltd
Shares: 5,130,122.00 · Class: 5.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001879713-25-000002
- Form type
- SCHEDULE 13G
- Filer
- Cardiol Therapeutics Inc.
- CIK
- CIK 1702123
- Filed
- Oct 23, 2025
- Reporting period
- Oct 17, 2025
- Description
- Schedule 13G beneficial ownership